Researchers outline their improved lipid-polymer nanoparticle for holding mRNA that is stable when nebulized and successfully ...

One class of drugs that is frequently used in a nebulized form is the opioids. The mechanism of action of nebulized opioids is uncertain, but it is thought that the opioids either act on receptors ...

Researchers outline their improved lipid-polymer nanoparticle for holding mRNA that is stable when nebulized and successfully ...

A groundbreaking study introduces stable inhalable mRNA treatment using nanoparticles that hold up during nebulization, ...

Inhalation (nebulized or aerosolized) is the only known method that increases GSH's levels in the ELF. A review of the literature was conducted to examine the clinical effectiveness of inhaled GSH ...

In this article, we take a look at five biotech companies developing potentially transformative medicines to treat cystic ...

United Therapeutics’ UTHR third-quarter 2024 earnings of $6.39 per share beat the Zacks Consensus Estimate of $6.18. Earnings ...

Argus analyst Jasper Hellweg raised the firm’s price target on United Therapeutics (UTHR) to $400 from $360 and keeps a Buy rating on the ...

This early-stage study is expected to recruit up to 12 patients who are to receive nebulized solution of KB408. It is expected that interim data from it will be released in Q4 of 2024. This ...

United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, today announced its financial results for the quarter ended September 30 ...

Ohtuvayre™ (ensifentrine) launch recorded Q3 net sales of $5.6 million and October net sales exceeded Q3Through October more than 2,200 unique ...

Received tentative approval from the FDA for YUTREPIATM (treprostinil) inhalation powder for both pulmonary arterial hypertension (PAH) ...